Differing Approaches to Managing the Chronic Breathlessness Syndrome in Advanced COPD: A Multi-National Survey of Specialists

References

• GOLD. Global initiative for chronic obstructive lung disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD (2018 report); 2018 [accessed June 2018]. Available from: http://www.goldcopd.org.
   Google Scholar
• Blinderman CD, Homel P, Billings JA, Tennstedt S, Portenoy RK. Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. J Pain Symptom Manage. 2009;38(1):115–23.
   PubMed Web of Science ®Google Scholar
• Johnson MJ, Yorke J, Hansen-Flaschen J, Lansing R, Ekstrom M, Similowski T, Currow DC. Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness. Eur Respir J. 2017;49(5).
   Web of Science ®Google Scholar
• Marciniuk DD, Goodridge D, Hernandez P, Rocker G, Balter M, Bailey P, et al. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. Can Respir J. 2011;18(2):69–78.
   PubMed Web of Science ®Google Scholar
• Yang I, Dabscheck E, George J, Jenkins S, McDonald C, McDonald V, et al. The COPD-X Plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease 2017. Version 2.52, December 2017 [accessed February 2018]. Available from: http://www.copdx.org.au.
   Google Scholar
• Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ. 2003;327(7414):523–8.
   PubMed Web of Science ®Google Scholar
• Barnes H, McDonald J, Smallwood N, Manser R. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database Syst Rev. 2016;3:CD011008.
   PubMedGoogle Scholar
• Currow DC, McDonald C, Oaten S, Kenny B, Allcroft P, Frith P, et al. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manage. 2011;42(3):388–99.
   PubMed Web of Science ®Google Scholar
• Currow DC, Plummer J, Frith P, Abernethy AP. Can we predict which patients with refractory dyspnea will respond to opioids? J Palliat Med. 2007;10(5):1031–6.
   PubMed Web of Science ®Google Scholar
• Ekstrom MP, Bornefalk-Hermansson A, Abernethy AP, Currow DC. Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study. BMJ. 2014;348:g445.
   PubMed Web of Science ®Google Scholar
• Smallwood N, Le B, Currow D, Irving L, Philip J. Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease. Int Med J. 2015;45(9):898–904.
   Google Scholar
• Mahler DA, Selecky PA, Harrod CG, Benditt JO, Carrieri-Kohlman V, Curtis JR, et al. American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease. Chest. 2010;137(3):674–91.
   PubMed Web of Science ®Google Scholar
• Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185(4):435–52.
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare (AIHW). Palliative care services in Australia; 2017 [accessed 2017 November 10]. Available from http://www.aihw.gov.au/reports/palliative-care-services/palliative-care-services-in-australia/contents/palliative-care-workforce.
   Google Scholar
• Ahmadi Z, Bernelid E, Currow DC, Ekstrom M. Prescription of opioids for breathlessness in end-stage COPD: a national population-based study. Int J Chron Obstruct Pulmon Dis. 2016;11:2651–7.
   PubMed Web of Science ®Google Scholar
• Ahmadi Z, Lundstrom S, Janson C, Strang P, Emtner M, Currow DC, et al. End-of-life care in oxygen-dependent COPD and cancer: a national population-based study. Eur Respir J. 2015;46(4):1190–3.
   PubMed Web of Science ®Google Scholar
• Currow DC, Abernethy AP, Ko DN. The active identification and management of chronic refractory breathlessness is a human right. Thorax. 2014;69(4):393–4.
   PubMed Web of Science ®Google Scholar
• Johnson MJ, Bowden JA, Abernethy AP, Currow DC. To what causes do people attribute their chronic breathlessness? A population survey. J Palliat Med. 2012;15(7):744–50.
   PubMed Web of Science ®Google Scholar
• Mullerova H, Lu C, Li H, Tabberer M. Prevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary care. PLoS One. 2014;9(1):e85540.
   PubMed Web of Science ®Google Scholar
• Rosenwax L, Spilsbury K, McNamara BA, Semmens JB. A retrospective population based cohort study of access to specialist palliative care in the last year of life: who is still missing out a decade on? BMC Palliat Care. 2016;15:46.
   PubMed Web of Science ®Google Scholar
• Walke LM, Byers AL, Tinetti ME, Dubin JA, McCorkle R, Fried TR. Range and severity of symptoms over time among older adults with chronic obstructive pulmonary disease and heart failure. Arch Intern Med. 2007;167(22):2503–8.
   PubMed Web of Science ®Google Scholar
• Hadjiphilippou S, Odogwu SE, Dand P. Doctors’ attitudes towards prescribing opioids for refractory dyspnoea: a single-centred study. BMJ Support Palliat Care. 2014.
   PubMedGoogle Scholar
• Young J, Donahue M, Farquhar M, Simpson C, Rocker G. Using opioids to treat dyspnea in advanced COPD: attitudes and experiences of family physicians and respiratory therapists. Can Fam Physician. 2012;58(7):e401–7.
   PubMed Web of Science ®Google Scholar
• Australian Institue of Health and Welfare. Medical practitioners workforce 2015; 2017 [accessed 2017 November 10]. Available from http://www.aihw.gov.au/reports/workforce/medical-practitioners-workforce-2015/contents/what-types-of-medical-practitioners-are-there.
   Google Scholar
• Royal College of Physicians. Census of consultant physicians and specialty traines in the UK: palliative medicine 2013-2014; 2015 [accessed 2016 August 10]. Available from http://www.jrcptb.org.uk.
   Google Scholar
• Royal College of Physicians.. Census of consultant physicians and higher specialty trainees in the UK 2014-2015; 2016 [accessed 2017 November 10]. Available from http://www.jrcptb.org.uk.
   Google Scholar
• Cullen A. The Medical Council of New Zealand: The New Zealand Medical Workforce in 2013 and 2014; [accessed 2016 August 10]. Available from http://www.mcnz.org.nz/assets/News-and-Publications/Workforce-Surveys/2013-2014.pdf.
   Google Scholar
• McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;(2):CD003793.
   PubMed Web of Science ®Google Scholar
• Steiner M, Holzhauer-Barrie J, Lowe D, Searle L, Skipper E, Welham S, et al. Pulmonary rehabilitation: steps to breathe better. National Chronic Obstructive Pulmonary Disease (COPD) Audit Programme: clinical audit of pulmonary rehabilitation services in England and Wales 2015. National clinical audit report. London: RCP, February 2016; [accessed 2017 November 21]. Available from http://www.rcplondon.ac.uk/projects/outputs/pulmonary-rehabilitation-steps-breathe-better.
   Google Scholar
• Ferreira DH, Silva JP, Quinn S, Abernethy AP, Johnson MJ, Oxberry SG, et al. Blinded patient preference for morphine compared to placebo in the setting of chronic refractory breathlessness–an exploratory study. J Pain Symptom Manage. 2016;51(2):247–54.
   PubMed Web of Science ®Google Scholar
• Ekstrom M, Bajwah S, Bland JM, Currow DC, Hussain J, Johnson MJ. One evidence base; three stories: do opioids relieve chronic breathlessness? Thorax. 2018;73(1):88–90.
   PubMed Web of Science ®Google Scholar
• Smallwood N, Barnes H, McDonald J, Manser R. Author reply. Intern Med J . 2018;48(4):486–7.
   PubMedGoogle Scholar
• Gaspar C, Alfarroba S, Telo L, Gomes C, Barbara C. End-of-life care in COPD: a survey carried out with Portuguese pulmonologists. Rev Port Pneumol. 2014;20(3):123–30.
   PubMed Web of Science ®Google Scholar
• Janssen DJ, de Hosson SM, bij de Vaate E, Mooren KJ, Baas AA. Attitudes toward opioids for refractory dyspnea in COPD among Dutch chest physicians. Chron Respir Dis. 2015;12(2):85–92.
   PubMed Web of Science ®Google Scholar
• Ecenarro PS, Iguiniz MI, Tejada SP, Malanda NM, Imizcoz MA, Marlasca LA, et al. Management of COPD in end-of-life care by Spanish pulmonologists. COPD. 2018:1–6.
   Google Scholar
• Smallwood N, Gaffney N, Gorelik A, Irving L, Le B, Philip J. Junior doctors’ attitudes to opioids for refractory breathlessness in patients with advanced chronic obstructive pulmonary disease. Int Med J. 2017;47(9):1050–6.
   Google Scholar
• Abdallah SJ, Wilkinson-Maitland C, Saad N, Li PZ, Smith BM, Bourbeau J, et al. Effect of morphine on breathlessness and exercise endurance in advanced COPD: a randomised crossover trial. Eur Respir J. 2017;50(4).
   PubMed Web of Science ®Google Scholar
• Lanken PN, Terry PB, Delisser HM, Fahy BF, Hansen-Flaschen J, Heffner JE, et al. An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med. 2008;177(8):912–27.
   PubMed Web of Science ®Google Scholar
• Rocker GM, Young J, Horton R. Using opioids to treat dyspnea in advanced COPD: a survey of Canadian clinicians. Chest. 2008;134(4 Suppl 2):s29001.
   Google Scholar
• Politis J, Eastman P, Le B, Furler A, Irving L, Smallwood N. TSANZ Poster Presentations TP079 General practitioners’ beliefs and experiences when caring for patients with severe chronic obstructive disease and refractory breathlessness. Respirology. 2017;22(Suppl 2):146.
   Google Scholar
• Verberkt CA, van den Beuken-van Everdingen MHJ, Schols J, Datla S, Dirksen CD, Johnson MJ, et al. Respiratory adverse effects of opioids for breathlessness: a systematic review and meta-analysis. Eur Respir J. 2017;50(5).
   PubMed Web of Science ®Google Scholar
• Simon ST, Higginson IJ, Booth S, Harding R, Weingartner V, Bausewein C. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev. 2016;10:CD007354.
   PubMedGoogle Scholar
• Smallwood N, Bartlett C, Taverner J, Le B, Irving L, Philip J. Palliation of patients with chronic obstructive pulmonary disease at the end of life. Respirology. 2016;21(Suppl. 2):143.
   PubMedGoogle Scholar
• Philip J, Crawford G, Brand C, Gold M, Miller B, Hudson P, et al. A conceptual model: redesigning how we provide palliative care for patients with chronic obstructive pulmonary disease. Palliat Support Care. 2017:1–9.
   PubMed Web of Science ®Google Scholar
• Higginson IJ, Bausewein C, Reilly CC, Gao W, Gysels M, Dzingina M, et al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med. 2014;2(12):979–87.
   PubMed Web of Science ®Google Scholar
• Smallwood N, Thompson M, Warrender-Sparkes M, Eastman P, Le B, Irving L, et al. Integrated respiratory and palliative care may improve outcomes in advanced lung disease. ERJ Open Res. 2018;4:00102–2017.
   PubMedGoogle Scholar